Market Research

How is Rising Number of Cancer Cases Driving Gene Therapy Market?

Jun 25, 2020 12:19 PM ET

iCrowd Newswire – Jun 25, 2020

The burden of chronic diseases has only been increasing since past few years. The cases for cancer, for example, are growing rapidly. According to the American Cancer Society, from 2016–2019, the number of new cases of cancer in the U.S. increased from 1,685,210 to 1,762,450, and the cancer mortality rose from 595,690 to 606,880 during the same time period. Doubtless, a number of advancements have been made in the medical industry for developing a proper cure for cancer and other rare chronic diseases, however, the fact remains that there is a long way to go before anything certain comes to light.

Request to view sample of this market research:

The advancements regarding gene therapy though can significantly aid in getting closer to dealing properly with several chronic diseases. Gene therapy is designed for introducing genetic material into cells for compensating for abnormal genes or for making a beneficial protein. In case a mutated gene causes an essential protein to be faulty or non-existent, gene therapy may potentially be able to introducing a new copy of the gene for restoring the function of the protein. Attributed to these reasons, the gene therapy market generated revenue of $3,407.5 million in 2019 and is expected to advance at a 31.1% CAGR during 2020–2030.

In 2019, North America was the largest gene therapy market, which is ascribed to the rising number of cancer and rare disease cases and the presence of a large number of key companies in the region. In addition to this, various gene therapy products are getting regulatory approvals in North America. Other than this, the adoption of gene therapy is also projected to rise substantially in the Asia-Pacific because of the cost-effective labor and rising activities of major industry players.

Pre-Purchase Inquiry at:

bluebird bio Inc., Spark Therapeutics Inc., Amgen Inc., Orchard Therapeutics plc, Thermo Fisher Scientific Inc., REGENXBIO Inc., Pfizer Inc., Applied Genetic Technologies Corporation, Novartis AG, and Adverum Biotechnologies Inc. are the major global gene therapy market players.

The objective of this research includes;

  • Historical and the present size of the gene therapy market
  • Future potential of the market through its forecast for the period 2020– 2030
  • Historical and the present size of the market segments and understand their comparative future potential
  • Potential of on-demand logistics services, so the market players make informed decisions on the sales of their offerings
  • Competitive scenario of various market segments across key countries in several regions for uncovering market opportunities for the stakeholders
  • Major players operating in the gene therapy market and their service offerings
  • Recent strategic developments by the major players in the market

About P&S Intelligence

P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact Information:

P&S Intelligence
International: +1-347-960-6455
Email: [email protected]


Keywords:    Gene Therapy Market, Gene Therapy Industry, Gene Therapy Market Trends, Global Gene Therapy Market

Add Comment

Click here to post a comment

Your email address will not be published. Required fields are marked *